{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:13:45Z","timestamp":1793650425748,"version":"4.5.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR18\/00042"],"award-info":[{"award-number":["JR18\/00042"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016003","name":"Istanbul Universitesi-Cerrahpasa","doi-asserted-by":"publisher","award":["TOA-2021-35251"],"award-info":[{"award-number":["TOA-2021-35251"]}],"id":[{"id":"10.13039\/501100016003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["GAIN 01GM1910A"],"award-info":[{"award-number":["GAIN 01GM1910A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC-2189"],"award-info":[{"award-number":["EXC-2189"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390939984"],"award-info":[{"award-number":["390939984"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010571","name":"BMBF Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021729","name":"Medizinische Fakult\u00e4t der Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002957","name":"Technische Universitat Dresden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031031","name":"Kinderspital Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jaci.2023.10.018","type":"journal-article","created":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T10:20:21Z","timestamp":1699179621000},"page":"275-286.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: An ESID\/EBMT-IEWP retrospective study"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-7912","authenticated-orcid":false,"given":"Marco","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Olbrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Aumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Bakhtiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Barlogis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"von Bismarck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00e9ta","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline P.","family":"Buddingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Cagdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Castelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmuganathan","family":"Chandrakasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritika","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cougoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Crickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmeen","family":"Dara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dey\u00e0-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Farmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Formankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Ignacio","family":"Gonzalez-Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif Gunnar","family":"Hanitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Hanzlikov\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Hauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ivorra-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kisand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca","family":"Kiykim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"K\u00f6rholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Ronan","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"van Montfrans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Nademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Nelken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhag","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvi","family":"Plado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ramakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Redlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Rieux-Laucat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques G.","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Rodina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9rsio Roxo","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Salou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shcherbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Touzot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekrem","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan C.","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko R.J.","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Neth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6217-1556","authenticated-orcid":false,"given":"Carsten","family":"Speckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.10.018_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671755","article-title":"Primary immune regulatory disorders with an autoimmune lymphoproliferative syndrome-like phenotype: immunologic evaluation, early diagnosis and management","volume":"12","author":"L\u00f3pez-Nevado","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib2","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.1901477","article-title":"Translating JAKs to Jakinibs","volume":"204","author":"Gadina","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2021.08.004","article-title":"JAK-STAT signaling in human disease: from genetic syndromes to clinical inhibition","volume":"148","author":"Luo","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib4","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2023.10.018_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.717388","article-title":"Emerging place of JAK inhibitors in the treatment of inborn errors of immunity","volume":"12","author":"Hadjadj","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib6","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.10.018_bib7","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.10.018_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","article-title":"Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations","volume":"141","author":"Leiding","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib11","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s10875-021-01163-8","article-title":"Immunogenicity and safety of COVID-19 mRNA vaccine in STAT1 GOF patients","volume":"42","author":"Bloomfield","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10875-023-01454-2","article-title":"STAT1 gain-of-function and hidradenitis suppurativa successfully managed with baricitinib","volume":"43","author":"Olbrich","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10875-022-01257-x","article-title":"Impact of JAK inhibitors in pediatric patients with STAT1 gain of function (GOF) mutations\u201410 children and review of the literature","volume":"42","author":"Dey\u00e0-Mart\u00ednez","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/eji.201847955","article-title":"Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined","volume":"49","author":"Kaleviste","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s10875-018-0513-z","article-title":"Aortic calcification in a patient with a gain-of-function STAT1 mutation","volume":"38","author":"Smyth","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s10875-021-01081-9","article-title":"SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under ruxolitinib therapy\u2014a matter of balance?","volume":"41","author":"Hern\u00e1ndez","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10875-019-00687-4","article-title":"Novel gain-of-function mutation in STAT1 sumoylation site leads to CMC\/CID phenotype responsive to ruxolitinib","volume":"39","author":"Shehri","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/rccm.201906-1204LE","article-title":"Successful treatment of interstitial lung disease in STAT3 gain-of-function using JAK inhibitors","volume":"202","author":"Silva-Carmona","year":"2020","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.jaci.2023.10.018_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106015","article-title":"Successful treatment of oral potentially malignant lesions with ruxolitinib in STAT3 gain-of-function disease","volume":"132","author":"Mulvihill","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jaci.2023.10.018_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2023.10.018_bib23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10875-020-00914-3","article-title":"Life-saving, dose-adjusted, targeted therapy in a patient with a STAT3 gain-of-function mutation","volume":"41","author":"Sarfati","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib24","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10875-020-00864-w","article-title":"Ruxolitinib controls lymphoproliferation and diabetes in a STAT3-GOF patient","volume":"40","author":"Wegehaupt","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2016-09-737817","article-title":"Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea","volume":"129","author":"Ma","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.10.018_bib26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaip.2020.11.050","article-title":"JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease","volume":"9","author":"Eisenberg","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.10.018_bib27","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s10875-023-01522-7","article-title":"JAKi salvage therapy followed by curative cord blood transplantation in a XIAP-deficient infant with relapsing HLH","volume":"43","author":"Maccari","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/jcph.102","article-title":"Population pharmacokinetic analysis of orally-administered ruxolitinib (INCB018424 phosphate) in patients with primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) or post-essential thrombocythemia myelofibrosis (PET MF)","volume":"53","author":"Chen","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2023.10.018_bib29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/ciw020","article-title":"Ruxolitinib induces interleukin 17 and ameliorates chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation","volume":"62","author":"M\u00f6ssner","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2023.10.018_bib30","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2016.11.022","article-title":"Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation","volume":"139","author":"Weinacht","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib31","doi-asserted-by":"crossref","first-page":"ofx202","DOI":"10.1093\/ofid\/ofx202","article-title":"Risks of ruxolitinib in STAT1 gain of function associated severe fungal disease","volume":"4","author":"Zimmerman","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaci.2023.10.018_bib32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaci.2018.02.045","article-title":"Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)","volume":"142","author":"Meesilpavikkai","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10875-018-0519-6","article-title":"Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation","volume":"38","author":"Bloomfield","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib34","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib35","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1097\/MPG.0000000000002854","article-title":"Ruxolitinib response in an infant with very-early-onset inflammatory bowel disease and gain-of-function STAT1 mutation","volume":"71","author":"Acker","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2023.10.018_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12185-020-02860-7","article-title":"Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation","volume":"112","author":"Moriya","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jaci.2023.10.018_bib37","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMc2022226","article-title":"STAT1 gain of function, type 1 diabetes, and reversal with JAK inhibition","volume":"383","author":"Chaimowitz","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.10.018_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.medj.2021.12.003","article-title":"JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia","volume":"3","author":"Rosenberg","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.jaci.2023.10.018_bib39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10875-020-00943-y","article-title":"Stepwise reversal of immune dysregulation due to STAT1 gain-of-function mutation following ruxolitinib bridge therapy and transplantation","volume":"41","author":"Kayaoglu","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928213","article-title":"Case report: a STAT1 gain-of-function mutation causes a syndrome of combined immunodeficiency, autoimmunity and pure red cell aplasia","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib41","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.1111\/jdv.18326","article-title":"Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation","volume":"36","author":"Olivier","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2023.10.018_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10875-022-01351-0","article-title":"Three adult cases of STAT1 gain-of-function with chronic mucocutaneous candidiasis treated with JAK inhibitors","volume":"43","author":"Borgstr\u00f6m","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib43","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2018.11.065","article-title":"Efficacy of ruxolitinib therapy in a patient with severe enterocolitis associated with a STAT3 gain-of-function mutation","volume":"156","author":"Parlato","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2023.10.018_bib44","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaci.2019.11.042","article-title":"Erythropoiesis defect observed in STAT3 GOF patients with severe anemia","volume":"145","author":"Mauracher","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib45","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10875-022-01232-6","article-title":"STAT 3 GOF with polycythemia: a twist to the tale\u2014first case report from India","volume":"42","author":"Gowri","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib46","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s10875-022-01346-x","article-title":"SOCS1 haploinsufficiency presenting as severe enthesitis, bone marrow hypocellularity, and refractory thrombocytopenia in a pediatric patient with subsequent response to JAK inhibition","volume":"42","author":"Michniacki","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib47","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jaci.2016.12.957","article-title":"JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome","volume":"139","author":"Bel","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib48","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.immuni.2020.07.006","article-title":"Complex autoinflammatory syndrome unveils fundamental principles of JAK1 kinase transcriptional and biochemical function","volume":"53","author":"Gruber","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2023.10.018_bib49","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa2202318","article-title":"Variant STAT4 and response to ruxolitinib in an autoinflammatory syndrome","volume":"388","author":"Baghdassarian","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.10.018_bib50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2023.01.023","article-title":"Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6","volume":"152","author":"Baris","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib51","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/j.jaip.2021.06.031","article-title":"Multicentric Castleman disease revealing complete signal transducer and activator of transcription 1 deficiency treated by JAK1\/2 inhibition","volume":"9","author":"Beaufils","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.10.018_bib52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1056\/NEJMoa1905633","article-title":"JAK inhibitor therapy in a child with inherited USP18 deficiency","volume":"382","author":"Alsohime","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.10.018_bib54","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.10.018_bib55","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/pbc.25575","article-title":"A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: a Children\u2019s Oncology Group phase 1 consortium study (ADVL1011)","volume":"62","author":"Loh","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaci.2023.10.018_bib56","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.10.018_bib57","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4065\/mcp.2011.0518","article-title":"Serious adverse events during ruxolitinib treatment discontinuation in patients with myelofibrosis","volume":"86","author":"Tefferi","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2023.10.018_bib58","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10875-016-0312-3","article-title":"Severe early-onset combined immunodeficiency due to heterozygous gain-of-function mutations in STAT1","volume":"36","author":"Baris","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10875-018-0575-y","article-title":"Hematopoietic stem cell transplantation in patients with heterozygous STAT1 gain-of-function mutation","volume":"39","author":"Kiykim","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib60","unstructured":"Buddingh EP, Slatter MA, Kykim A, Garcia LA, Chellapandian D, Formankova R, et\u00a0al. Outcome of patients with signal-transducer and activator of transcription 1 (STAT1) gain-of-function variants after haematopoietic stem cell transplantation. Paper presented at: European Society for Blood and Marrow Transplantation (ESBM) Midterm Meeting on New Indications in Immune Dysregulatory, Autoinflammatory, and Autoimmune Disease; June 22-24, 2023; Brescia, Italy. Abstract 1512."},{"key":"10.1016\/j.jaci.2023.10.018_bib61","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s10875-021-01163-8","article-title":"Immunogenicity and safety of COVID-19 mRNA vaccine in STAT1 GOF patients","volume":"42","author":"Bloomfield","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib62","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10875-023-01454-2","article-title":"STAT1 gain-of-function and hidradenitis suppurativa successfully managed with baricitinib","volume":"43","author":"Olbrich","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib63","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10875-022-01257-x","article-title":"Impact of JAK inhibitors in pediatric patients with STAT1 gain of function (GOF) mutations\u201410 children and review of the literature","volume":"42","author":"Dey\u00e0-Mart\u00ednez","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib64","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.10.018_bib65","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/eji.201847955","article-title":"Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined","volume":"49","author":"Kaleviste","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib66","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s10875-018-0513-z","article-title":"Aortic calcification in a patient with a gain-of-function STAT1 mutation","volume":"38","author":"Smyth","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib67","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s10875-021-01081-9","article-title":"SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under\u00a0ruxolitinib therapy\u2014a matter of balance?","volume":"41","author":"Hern\u00e1ndez","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib68","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10875-019-00687-4","article-title":"Novel gain-of-function mutation in STAT1 sumoylation site leads to CMC\/CID phenotype responsive to ruxolitinib","volume":"39","author":"Shehri","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib69","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib70","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/rccm.201906-1204LE","article-title":"Successful treatment of interstitial lung disease in STAT3 gain-of-function using JAK inhibitors","volume":"202","author":"Silva-Carmona","year":"2020","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.jaci.2023.10.018_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106015","article-title":"Successful treatment of oral potentially malignant lesions with ruxolitinib in STAT3 gain-of-function disease","volume":"132","author":"Mulvihill","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jaci.2023.10.018_bib72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib73","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2023.10.018_bib74","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10875-020-00914-3","article-title":"Life-saving, dose-adjusted, targeted therapy in a patient with a STAT3 gain-of-function mutation","volume":"41","author":"Sarfati","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib75","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10875-020-00864-w","article-title":"Ruxolitinib controls lymphoproliferation and diabetes in a STAT3-GOF patient","volume":"40","author":"Wegehaupt","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.10.018_bib76","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2016-09-737817","article-title":"Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea","volume":"129","author":"Ma","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.10.018_bib77","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaip.2020.11.050","article-title":"JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease","volume":"9","author":"Eisenberg","year":"2021","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923013908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923013908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:21:17Z","timestamp":1778714477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923013908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0091674923013908"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.10.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: An ESID\/EBMT-IEWP retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}